TMO Financial Facts
Operating Income: 541.1MProvision for Income Taxes: 45.6M
See Full Income Statement
Other Long-term Liabilities: 1.44B
Accounts payable: 941.7M
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | 7/24/24 *Est. | EPS Growth Rate | +1.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -3.5% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/26/23 | Q223 | $5.15 | $5.43 | -$0.28 | $10.69B | $10.99B |  |
 | | Details | |
10/26/11  |
 |
Q311 | $1.07 | $1.07 | $0.00 | $2.97B | $3B | = | | | Details |
| 4/26/23 | Q123 | $5.03 | $5.03 | $0.00 | $10.71B | $10.65B | |
| | Details | |
| 10/21/15 |
|
Q315 | $1.80 | $1.79 | +$0.01 | $4.12B | $4.1B |  |
| | Details |
| 1/28/16 |
|
Q415 | $2.12 | $2.11 | +$0.01 | $4.65B | $4.55B | |
| | Details |
| 1/30/20 | |
Q419 | $3.55 | $3.54 | +$0.01 | $6.83B | $6.78B | N/A | | | Details |
| 7/27/11 |
|
Q211 | $0.99 | $0.98 | +$0.01 | $2.9B | $2.84B | = | | | Details |
| 7/24/13 |
|
Q213 | $1.32 | $1.30 | +$0.02 | $3.24B | $3.22B | = | | | Details |
